Policy Analysis: Interrupted Time Series Methods

Dr. Michael Law is a Professor and Canada Research Chair in Access to Medicines at the University of British Columbia's School of Population and Public Health, where his groundbreaking research focuses on pharmaceutical policy and access to medicines. After completing his PhD in Health Policy from Harvard University and a post-doctoral fellowship at Harvard Medical School, he has built an impressive career combining academic excellence with practical policy impact. His research portfolio, supported by over $2.5 million in funding including CIHR grants, spans multiple countries including Canada, Rwanda, Uganda, Namibia, and Colombia. A graduate of the London School of Economics (MSc) and McMaster University's Arts & Sciences Program (BA&Sc), Law has published extensively in leading medical journals, with his work featured in prestigious media outlets like New Scientist, Forbes, The New York Times, and USA Today. His achievements include the Labelle Lectureship at McMaster University, the 2011 Paper of the Year Award from the Canadian Institute for Health Services and Policy Research, a CIHR New Investigator Award, and a Michael Smith Foundation for Health Research Scholar Award. At UBC, he excels in teaching pharmaceutical policy, health insurance, and healthcare systems, earning the Cortland MacKenzie Teaching Prize for outstanding teaching evaluations in the School of Population and Public Health.